Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR: BULLS AND BEARS! -- Ignore unavailable to you. Want to Upgrade?

To: BARRY ALLEN who wrote (5933)	5/13/1998 10:01:00 AM
From: OLD JAKE JUSTUS	Read Replies (1) \| Respond to of 8902

Thanks, for the information. As many folks have previously stated I believe that Reticulose when mass produced can compete most favorably with any and all of these much needed new drugs that are coming forward for final FDA approval. Dr. H, in my opinion, needs to get a fast track approval process for Reticulose. The world certainly needs this type of drug. One that is totally safe and effective. Time will tell, but I am very, very positive about the future of ADVR and Reticulose. The pioneer With the new idea Must start it operating With this feat He will beat Those still contemplating. From "The Great Business Quotations", Complied by Rolf B. White "When your work speaks for itself, don't interrupt." Henry J. Kaiser Take care, and many thanks!